MB Grant, A Afzal, P Spoerri, H Pan, LC … - eid, 2004 - informahealthcare.com Diabetic retinopathy (DR) is the most severe of several ocular complications of
diabetes. The earliest clinical signs of DR are microaneurysms and haemor-
rhages. Later signs include dilated, tortuous irregular veins and retinal ... Cited by 41 - Related articles - All 4 versions
R Simo, E Carrasco, M Garcia-Ramirez, C … - Current Diabetes Reviews, 2006 - ingentaconnect.com Abstract: Diabetic retinopathy continues to be the leading cause of legal
blindness among working-age individuals. The earliest histological features of
diabetic retinopathy include neuroretinal damage, capillary basement ... Cited by 36 - Related articles - BL Direct - All 2 versions
- ►diabetesjournals.org DR Hinton, C Spee, S He, S Weitz, W Usinger, … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—A significant increase in NH 2 -terminal CTGF fragment content was
found in vitreous samples from patients with active PDR when compared with
samples from nondiabetic patients (P < 0.0001) or patients with quiescent ... Cited by 27 - Related articles - BL Direct - All 5 versions
- ►vhebron.net [PDF] M Garcia-Ramirez, F Canals, C Hernández, N … - Diabetologia, 2007 - Springer Page 1. ARTICLE Proteomic analysis of human vitreous fluid by fluorescence-
based difference gel electrophoresis (DIGE): a new strategy ... Cited by 22 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org C Hernández, E Carrasco, R Casamitjana, R … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—There is growing evidence to indicate that somatostatin could be
added to the list of natural antiangiogenic factors that exist in the vitreous
fluid. In addition, a deficit of intravitreous somatostatin-like ... Cited by 22 - Related articles - BL Direct - All 5 versions
Y Bezerra, JA Fuselier, GA Peyman, H Oner, … - Retina, 2005 - journals.lww.com From the *Department of Ophthalmology and the †Peptide Research Laboratory of
the Department of Medicine, Tulane Uni- versity Health Sciences Center, New
Orleans, Louisiana; and ‡Mandeville, Louisiana. Joseph A. Fuselier, Dr. ... Cited by 14 - Related articles - All 2 versions
- ►diabetesjournals.org E Carrasco, C Hernández, A Miralles, P Huguet … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—A higher expression of SST was detected in RPE than neuroretina in
both groups. SST mRNA levels and SST-28 immunoreactivity were significantly
lower in both RPE and the neuroretina from diabetic donors compared with ... Cited by 11 - Related articles - BL Direct - All 4 versions
GM Comer, TA Ciulla - Expert Opin. Emerging Drugs, 2005 - informahealthcare.com Diabetic retinopathy (DR) is a potentially visually devastating complication of
chronic hyperglycaemia. Prospective, randomised clinical trials have deline-
ated the standard prevention protocols, including intensive glycaemic, ... Cited by 10 - Related articles - BL Direct - All 4 versions
C Hernández, R Simó - Expert Opinion in Investigational Drugs, 2007 - informahealthcare.com Proliferative diabetic retinopathy (PDR) demands both more effective and less
expensive biologically based treatments. Our understanding of the
pathophysiology of the disease is increasing as new biochemical pathways ... Cited by 9 - Related articles - BL Direct - All 5 versions
- Free from Publisher R Simó, E Carrasco, A Fonollosa, J García- … - Diabetes care, 2007 - Am Diabetes Assoc Although diabetic macular edema (DME) is the main cause of visual loss in type 2
diabetic patients (1), its pathogenic mechanisms have been much less studied
than proliferative diabetic retinopathy (PDR). The production of both ... Cited by 9 - Related articles - BL Direct - All 5 versions
